SCHEMBL6206899

SCHEMBL6206899

[CH2]c1cc2c(C)cccc2[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.53
DDO Q99489 1/20 0.53
KIF11 P52732 2/20 0.47
CYP1A2 P05177 5/20 0.42
CYP2C19 P33261 1/20 0.42
TNKS2 Q9H2K2 1/20 0.42
CYP2A6 P11509 3/20 0.42
FLT3 P36888 3/20 0.42
PDGFRB P09619 1/20 0.42
KIT P10721 1/20 0.42
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
AHR P35869 1/20 0.38
GAA P10253 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8230643 0.78 DAO (0.56) DAODDOKIF11CYP1A2CYP2C19
SCHEMBL29713806 0.78 DAO (0.56) DAODDOKIF11CYP1A2CYP2C19
Formaldehyde SCHEMBL28245545 0.78 DAO (0.56) DAODDOKIF11CYP1A2CYP2C19
SCHEMBL4071480 0.77 DAO (0.55) DAODDOKIF11CYP1A2CYP2C19
SCHEMBL30939503 0.77 DAO (0.55) DAODDOKIF11CYP1A2CYP2C19
SCHEMBL10441152 0.75 DAO (0.53) DAODDOKIF11CYP1A2CYP2C19
SCHEMBL12778111 0.75 DAO (0.53) DAODDOKIF11CYP1A2CYP2C19
SCHEMBL19373476 0.75 DAO (0.62) DAODDOKIF11CYP1A2CYP2C19
SCHEMBL27342758 0.75 DAO (0.49) DAODDOKIF11CYP1A2CYP2C19
SCHEMBL30667289 0.73 DAO (0.71) DAODDOKIF11CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021026672-A1 HETEROCYCLIC WDR5 INHIBITORS AS ANTI-CANCER COMPOUNDS NOVARTIS AG (CH) 2021-02-18 WO disclosed
EP-1503997-A1 CYSTEINE PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2005-02-09 EP disclosed
WO-2003097617-A1 CYSTEINE PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2003-11-27 WO disclosed